Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread

NCT04631029 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

NIH

Sponsor class

Conditions

Extensive Stage Lung Small Cell Carcinoma
Malignant Solid Neoplasm
Metastatic Malignant Neoplasm in the Brain

Interventions

BIOLOGICAL: Atezolizumab
DRUG: Carboplatin
DRUG: Entinostat
DRUG: Etoposide

Sponsor

National Cancer Institute (NCI)